The association of fasting plasma sulfur-containing compounds with BMI, serum lipids and apolipoproteins

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 22, Issue 12, 2012, Pages 1031-1038

  Elshorbagy, A K ^a,b   Valdivia Garcia, M ^a   Graham, I M ^c   Palma Reis, R ^d   Sales Luis, A ^d   Smith, A D ^a   Refsum, H ^a,e  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b ALEXANDRIA UNIVERSITY   (Egypt)

^c ADELAIDE AND MEATH HOSPITAL   (Ireland)

^d UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^e UNIVERSITY OF OSLO   (Norway)

Author keywords

Apolipoproteins; BMI; Cysteine; Glutathione; Methionine; Serum lipids; Sulfur amino acids; Taurine

Indexed keywords

APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SULFUR AMINO ACID; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD; BODY COMPOSITION; BODY MASS; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; DIET RESTRICTION; FEMALE; HUMAN; IRELAND; LIQUID CHROMATOGRAPHY; MALE; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; OBESITY; PORTUGAL; STATISTICAL MODEL; SWEDEN; TANDEM MASS SPECTROMETRY;

ADULT; AMINO ACIDS, SULFUR; APOLIPOPROTEINS B; BODY COMPOSITION; BODY MASS INDEX; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHROMATOGRAPHY, LIQUID; CROSS-SECTIONAL STUDIES; FASTING; FEMALE; HUMANS; IRELAND; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; PORTUGAL; SWEDEN; TANDEM MASS SPECTROMETRY; TRIGLYCERIDES;

RODENTIA;

EID: 84870396750     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2011.01.008     Document Type: Article

References (45)

1. El-Khairy L., Ueland P.M., Nygard O., Refsum H., Vollset S.E. Lifestyle and cardiovascular disease risk factors as determinants of total cysteine in plasma: the Hordaland homocysteine study. Am J Clin Nutr 1999, 70:1016-1024.
2. El-Khairy L., Vollset S.E., Refsum H., Ueland P.M. Predictors of change in plasma total cysteine: longitudinal findings from the Hordaland homocysteine study. Clin Chem 2003, 49:113-120.
3. Elshorbagy A.K., Nurk E., Gjesdal C.G., Tell G.S., Ueland P.M., Nygard O., et al. Homocysteine, cysteine, and body composition in the Hordaland homocysteine study: does cysteine link amino acid and lipid metabolism?. Am J Clin Nutr 2008, 88:738-746.
4. Elshorbagy A.K., Refsum H., Smith A.D., Graham I.M. The association of plasma cysteine and gamma-glutamyltransferase with BMI and obesity. Obesity (Silver Spring) 2009, 17:1435-1440.
5. Guttormsen A.B., Solheim E., Refsum H. Variation in plasma cystathionine and its relation to changes in plasma concentrations of homocysteine and methionine in healthy subjects during a 24-h observation period. Am J Clin Nutr 2004, 79:76-79.
6. Cohn J.S., McNamara J.R., Schaefer E.J. Lipoprotein cholesterol concentrations in the plasma of human subjects as measured in the fed and fasted states. Clin Chem 1988, 34:2456-2459.
7. El-Khairy L., Ueland P.M., Refsum H., Graham I.M., Vollset S.E. Plasma total cysteine as a risk factor for vascular disease: the European concerted action project. Circulation 2001, 103:2544-2549.
8. Huang X.F., Shelness G.S. Identification of cysteine pairs within the amino-terminal 5% of apolipoprotein B essential for hepatic lipoprotein assembly and secretion. J Biol Chem 1997, 272:31872-31876.
9. Olofsson S.O., Wiklund O., Boren J. Apolipoproteins A-I and B: biosynthesis, role in the development of atherosclerosis and targets for intervention against cardiovascular disease. Vasc Health Risk Manag 2007, 3:491-502.
10. Cummings M.H., Watts G.F., Pal C., Umpleby M., Hennessy T.R., Naoumova R., et al. Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in obesity: a stable isotope study. Clin Sci (Lond) 1995, 88:225-233.
11. Shew S.B., Keshen T.H., Jahoor F., Jaksic T. Assessment of cysteine synthesis in very low-birth weight neonates using a [13C6]glucose tracer. J Pediatr Surg 2005, 40:52-56.
12. Miller R.G., Keshen T.H., Jahoor F., Shew S.B., Jaksic T. Compartmentation of endogenously synthesized amino acids in neonates. J Surg Res 1996, 63:199-203.
13. Hsu C.C., Huang C.N., Hung Y.C., Yin M.C. Five cysteine-containing compounds have antioxidative activity in Balb/cA mice. J Nutr 2004, 134:149-152.
14. Hirche F., Schroder A., Knoth B., Stangl G.I., Eder K. Effect of dietary methionine on plasma and liver cholesterol concentrations in rats and expression of hepatic genes involved in cholesterol metabolism. Br J Nutr 2006, 95:879-888.
15. Malloy V.L., Krajcik R.A., Bailey S.J., Hristopoulos G., Plummer J.D., Orentreich N. Methionine restriction decreases visceral fat mass and preserves insulin action in aging male Fischer 344 rats independent of energy restriction. Aging Cell 2006, 5:305-314.
16. Stipanuk M.H. Role of the liver in regulation of body cysteine and taurine levels: a brief review. Neurochem Res 2004, 29:105-110.
17. Mochizuki H., Oda H., Yokogoshi H. Increasing effect of dietary taurine on the serum HDL-cholesterol concentration in rats. Biosci Biotechnol Biochem 1998, 62:578-579.
18. Choi M.J., Kim M.J., Chang K.J. The effect of dietary taurine supplementation on plasma and liver lipid concentrations and mineral metabolism in rats fed alcohol. Adv Exp Med Biol 2006, 583:243-250.
19. Yokogoshi H., Mochizuki H., Nanami K., Hida Y., Miyachi F., Oda H. Dietary taurine enhances cholesterol degradation and reduces serum and liver cholesterol concentrations in rats fed a high-cholesterol diet. J Nutr 1999, 129:1705-1712.
20. Nishimura N., Umeda C., Ona H., Yokogoshi H. The effect of taurine on plasma cholesterol concentration in genetic type 2 diabetic GK rats. J Nutr Sci Vitaminol (Tokyo) 2002, 48:483-490.
21. Fujihira E., Takahashi H., Nakazawa M. Effect of long-term feeding of taurine in hereditary hyperglycemic obese mice. Chem Pharm Bull (Tokyo) 1970, 18:1636-1642.
22. Tsuboyama-Kasaoka N., Shozawa C., Sano K., Kamei Y., Kasaoka S., Hosokawa Y., et al. Taurine (2-aminoethanesulfonic acid) deficiency creates a vicious circle promoting obesity. Endocrinology 2006, 147:3276-3284.
23. Graham I.M., Daly L.E., Refsum H.M., Robinson K., Brattstrom L.E., Ueland P.M., et al. Plasma homocysteine as a risk factor for vascular disease. The European concerted action project. Jama 1997, 277:1775-1781.
24. Refsum H., Grindflek A.W., Ueland P.M., Fredriksen A., Meyer K., Ulvik A., et al. Screening for serum total homocysteine in newborn children. Clin Chem 2004, 50:1769-1784.
25. Elshorbagy A.K., Valdivia-Garcia M., Refsum H., Smith A.D., Mattocks D.A., Perrone C.E. Sulfur amino acids in methionine-restricted rats: hyperhomocysteinemia. Nutrition 2010, 10.1016/j.nut.2009.09.017.
26. Mochizuki H., Oda H., Yokogoshi H. Dietary taurine potentiates polychlorinated biphenyl-induced hypercholesterolemia in rats*. J Nutr Biochem 2001, 12:109-115.
27. Matsushima Y., Sekine T., Kondo Y., Sakurai T., Kameo K., Tachibana M., et al. Effects of taurine on serum cholesterol levels and development of atherosclerosis in spontaneously hyperlipidaemic mice. Clin Exp Pharmacol Physiol 2003, 30:295-299.
28. Choi M.J., Kim J.H., Chang K.J. The effect of dietary taurine supplementation on plasma and liver lipid concentrations and free amino acid concentrations in rats fed a high-cholesterol diet. Adv Exp Med Biol 2006, 583:235-242.
29. Kinscherf R., Cafaltzis K., Roder F., Hildebrandt W., Edler L., Deigner H.P., et al. Cholesterol levels linked to abnormal plasma thiol concentrations and thiol/disulfide redox status in hyperlipidemic subjects. Free Radic Biol Med 2003, 35:1286-1292.
30. Serougne C., Felgines C., Ferezou J., Hajri T., Bertin C., Mazur A. Hypercholesterolemia induced by cholesterol- or cystine-enriched diets is characterized by different plasma lipoprotein and apolipoprotein concentrations in rats. J Nutr 1995, 125:35-41.
31. Adiels M., Olofsson S.O., Taskinen M.R., Boren J. Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler Thromb Vasc Biol 2008, 28:1225-1236.
32. Giral P., Jacob N., Dourmap C., Hansel B., Carrie A., Bruckert E., et al. Elevated gamma-glutamyltransferase activity and perturbed thiol profile are associated with features of metabolic syndrome. Arterioscler Thromb Vasc Biol 2008, 28:587-593.
33. Finkelstein J.D. Methionine metabolism in mammals. J Nutr Biochem 1990, 1:228-237.
34. Newgard C.B., An J., Bain J.R., Muehlbauer M.J., Stevens R.D., Lien L.F., et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 2009, 9:311-326.
35. Virtanen J.K., Voutilainen S., Rissanen T.H., Happonen P., Mursu J., Laukkanen J.A., et al. High dietary methionine intake increases the risk of acute coronary events in middle-aged men. Nutr Metab Cardiovasc Dis 2006, 16:113-120.
36. Finkelstein J.D., Martin J.J. Methionine metabolism in mammals. Adaptation to methionine excess. J Biol Chem 1986, 261:1582-1587.
37. Ganji V., Kafai M.R. Demographic, health, lifestyle, and blood vitamin determinants of serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr 2003, 77:826-833.
38. Trautwein E.A., Hayes K.C. Plasma and whole blood taurine concentrations respond differently to taurine supplementation (humans) and depletion (cats). Z Ernahrungswiss 1995, 34:137-142.
39. Mizushima S., Nara Y., Sawamura M., Yamori Y. Effects of oral taurine supplementation on lipids and sympathetic nerve tone. Adv Exp Med Biol 1996, 403:615-622.
40. Brons C., Spohr C., Storgaard H., Dyerberg J., Vaag A. Effect of taurine treatment on insulin secretion and action, and on serum lipid levels in overweight men with a genetic predisposition for type II diabetes mellitus. Eur J Clin Nutr 2004, 58:1239-1247.
41. Zhang M., Bi L.F., Fang J.H., Su X.L., Da G.L., Kuwamori T., et al. Beneficial effects of taurine on serum lipids in overweight or obese non-diabetic subjects. Amino Acids 2004, 26:267-271.
42. Yamori Y., Liu L., Mizushima S., Ikeda K., Nara Y. Male cardiovascular mortality and dietary markers in 25 population samples of 16 countries. J Hypertens 2006, 24:1499-1505.
43. Mannery Y.O., Ziegler T.R., Park Y., Jones D.P. Oxidation of plasma cysteine/cystine and GSH/GSSG redox potentials by acetaminophen and sulfur amino acid insufficiency in humans. J Pharmacol Exp Ther 2010, 333:939-947.
44. Larsson S.C., Giovannucci E., Wolk A. Methionine and vitamin B6 intake and risk of pancreatic cancer: a prospective study of Swedish women and men. Gastroenterology 2007, 132:113-118.
45. Elshorbagy A.K., Valdivia-Garcia M., Mattocks D.A., Plummer J.D., Smith A.D., Drevon C.A., et al. Cysteine supplementation reverses methionine restriction effects on rat adiposity: significance of stearoyl-coenzyme A desaturase. J Lipid Res 2011, 52(1):104-112.